Psoriatic Arthritis
📧 Sign up to get email alerts when something new happens for Psoriatic Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-02-09Clinical Trial Update: A Study to Investigate Efficacy, Tolerability and Safety of ABY-035 in Patients With Active Psoriatic Arthritis [Phase 2]
Phase 2 clinical trial evaluating ABY-035 for efficacy, tolerability, and safety in active psoriatic arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2024-02-08Clinical Trial Update: Efficacy And Safety Of Tofacitinib In Chinese Subjects With Active Psoriatic Arthritis [Phase 3]
Phase 3 trial update on tofacitinib in Chinese patients with active psoriatic arthritis reports efficacy and safety results.
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: Efficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis. [Phase 4]
This Phase 4 trial evaluated the efficacy, safety, and tolerability of apremilast for early oligoarticular psoriatic arthritis; the study ha…
-
CLINICAL_TRIALS trial_result · 2023-12-13Clinical Trial Update: Bioequivalence Study of Two Products of Apremilast 30 mg Tablets in Healthy, Adult, Human Subjects [Phase 3]
Phase 3 bioequivalence study of two Apremilast 30 mg tablet products completed in healthy adults.
-
CLINICAL_TRIALS trial_result · 2023-12-01Clinical Trial Update: A Study to Evaluate the Long-Term Safety and Efficacy of Bimekizumab in Subjects With Psoriatic Arthritis [Phase 2]
Phase 2 trial assessing long-term safety and efficacy of bimekizumab in psoriatic arthritis has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-11-30Clinical Trial Update: A Study to Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Subcutaneous Self-injection of Bimekizumab Solution by Subjects With Active Psoriatic Arthritis [Phase 3]
A Phase 3 clinical trial evaluated the safe and effective use of a prefilled safety syringe or auto-injector for subcutaneous self-injection…
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: Comparative Study of BAT2506 With Simponi® in Participants With Active Psoriatic Arthritis [Phase 3]
A Phase 3 clinical trial comparing BAT2506 with Simponi in participants with active psoriatic arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: PsA Secukinumab XCT Structural Progression Study [Phase 4]
Phase 4 trial update for secukinumab in psoriatic arthritis completed, reporting structural progression study results.
-
CLINICAL_TRIALS trial_result · 2023-08-25Clinical Trial Update: A Phase 3 Clinical Study of KHK 4827 [Phase 3]
Phase 3 trial update for KHK 4827 across psoriasis-related conditions; study completed.
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: Study to Evaluate the Effect of Filgotinib on Semen Parameters in Adult Males With Active Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, or Non-radiographic Axial Spondyloarthritis [Phase 2]
This Phase 2 trial update reports results from a study evaluating the effect of Filgotinib on semen parameters in adult males with active rh…
-
CLINICAL_TRIALS trial_result · 2023-02-09Clinical Trial Update: To Evaluate the Efficacy and Safety of SHR0302 Tablet in Subjects of Active Psoriatic Arthritis [Phase 3]
Phase 3 clinical trial update evaluating SHR0302 tablet for efficacy and safety in active psoriatic arthritis.
-
CLINICAL_TRIALS trial_result · 2023-01-25Clinical Trial Update: National Observational Study On The Use Of Inflectra™ An Infliximab Biosimilar In Real Life
A national observational study assessing the real-world use of Inflectra (infliximab biosimilar) across multiple inflammatory diseases compl…
-
CLINICAL_TRIALS trial_result · 2023-01-20Clinical Trial Update: A Study of Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic Arthritis [Phase 4]
Phase 4 clinical trial evaluating golimumab in Indian participants with active ankylosing spondylitis or psoriatic arthritis has completed. …
-
CLINICAL_TRIALS trial_result · 2022-12-19Clinical Trial Update: A Study to Evaluate the Impact of Apremilast on Magnetic Resonance Imaging (MRI) Outcomes in Adults With Psoriatic Arthritis [Phase 4]
Phase 4 clinical trial evaluating the effect of apremilast on MRI outcomes in adults with Psoriatic arthritis; results have been posted.
-
CLINICAL_TRIALS trial_result · 2022-11-14Clinical Trial Update: Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis [Phase 3]
Phase 3 trial investigating how tapering immunosuppressants affects maintaining minimal disease activity in adults with psoriatic arthritis.
-
CLINICAL_TRIALS trial_result · 2022-07-26Clinical Trial Update: Tofacitinib for Reduction of Spinal Inflammation in Patients With Psoriatic ArthritiS PresenTing With Axial InvOlvement [Phase 2]
Phase 2 trial evaluating tofacitinib for reducing spinal inflammation in psoriatic arthritis with axial involvement.
-
CLINICAL_TRIALS trial_result · 2022-05-16Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Are Naive to Biologic DMARD Therapy [Phase 3]
Phase 3 trial evaluating filgotinib in biologic DMARD-naive active psoriatic arthritis was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2022-03-18Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy [Phase 3]
Phase 3 trial evaluating filgotinib in active psoriatic arthritis patients intolerant or inadequate response to biologic DMARD therapy was t…
-
CLINICAL_TRIALS trial_result · 2022-03-11Clinical Trial Update: MYL-1401A Efficacy and Safety Comparability Study to Humira® [Phase 3]
Phase 3 trial comparing MYL-1401A to Humira for psoriasis, arthritis, and psoriatic arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2022-03-04Clinical Trial Update: A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis [Phase 3]
Phase 3 trial evaluating the efficacy and safety of Bimekizumab in adults with moderate to severe chronic plaque psoriasis, using an initial…
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) [Phase 3]
Phase 3 trial comparing risankizumab to placebo in active psoriatic arthritis, including participants with prior inadequate response or into…
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) [Phase 3]
A Phase 3 trial comparing risankizumab to placebo in active psoriatic arthritis, including patients with prior inadequate response or intole…
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: Impact of Concomitant MTX on Efficacy, Safety and Adherence of Ustekinumab-treatment in Patients With Active PsA [Phase 3]
Phase 3 clinical trial update examining how concomitant methotrexate affects the efficacy, safety, and adherence of ustekinumab in active ps…
-
CLINICAL_TRIALS trial_result · 2022-02-24Clinical Trial Update: A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy [Phase 3]
Phase 3 trial comparing risankizumab to placebo in adults with active psoriatic arthritis who had inadequate response or intolerance to at l…
-
CLINICAL_TRIALS trial_result · 2022-02-03Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis [Phase 3]
Phase 3 study evaluating the efficacy and safety of bimekizumab versus placebo and an active comparator in adults with moderate-to-severe ch…